More importantly, the modest increase in the expression of p-FOXO3a induced by AsIII was successfully corrected by the addition of Tetra (Fig. 7), suggesting that the two drugs worked coordinately to downregulate phosphorylated FOXO3a in tumor tissue, consequently maintained its function as tumor suppressor. Here, FOXO3 is linked to neoplasm.